RxDoctor Payments Data

Michael Bullen, MD

Obstetrics & Gynecology · Knoxville, TNNPI 1578646436

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,375 of the $13,433 with a category attached, or 92.1%. Merck accounts for 74.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $4,510 and has fallen 94.1% since, to $266 in 2025. Among obstetrics & gynecology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,433in general payments, 2019–2025

Across 48 payments — averaging $279.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$10K
  • Organon$3K
  • Mayne Pharma Commercial LLC$186
  • Exeltis, USA Inc.$103
  • AbbVie$58
  • Hologic Sales And Service, LLC$54
  • plus $232 from 11 others

What the payments were for

  • Speaking & faculty fees$12,37592%
  • Travel & lodging$3813%
  • Food & beverage$6655%
  • Education$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,433 in reported general payments places this provider in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$9,144
Medicare patients
53
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol59$4,610
Clobetasol Propionate16$243
Tarina Fe 1-20 EqNorethindrone-E.Estradiol-Iron13$158

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →